Laetitia Lebrun
Overview
Explore the profile of Laetitia Lebrun including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
284
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lebrun L, Gilis N, Dausort M, Gillard C, Rusu S, Slimani K, et al.
Sci Rep
. 2025 Jan;
15(1):2857.
PMID: 39843975
Over the past decade, neuropathological diagnosis has undergone significant changes, integrating morphological features with molecular biomarkers. The molecular era has successfully refined neuropathological diagnostic accuracy; however, a substantial number of...
2.
Ahmed M, Sieben A, Van Genechten T, Libbrecht S, Gilis N, De Praeter M, et al.
Cancers (Basel)
. 2024 Oct;
16(19).
PMID: 39409964
Central Nervous System (CNS) pediatric tumors represent the most common solid tumors in children with a wide variability in terms of survival and therapeutic response. By contrast to their adult...
3.
Duerinck J, Lescrauwaet L, Dirven I, Delhaye J, Stevens L, Geeraerts X, et al.
Neuro Oncol
. 2024 Oct;
26(12):2208-2221.
PMID: 39406392
Background: Recurrent high-grade glioma (rHGG) lacks effective life-prolonging treatments and the efficacy of systemic PD-1 and CTLA-4 immune checkpoint inhibitors is limited. The multi-cohort Glitipni phase I trial investigates the...
4.
Jaafari A, Mansour S, Lebrun L, Kaefer K, Attou R
Diagnostics (Basel)
. 2024 Jul;
14(13).
PMID: 39001341
Invasive aspergillosis (IA) represents a common form of fungal infection caused by various species of that most frequently affect immunocompromised patients. Typically, this disease occurs preferentially in high-risk groups including...
5.
Magerman C, Boros E, Preziosi M, Lhoir S, Gilis N, De Witte O, et al.
Front Endocrinol (Lausanne)
. 2024 Jul;
15:1297132.
PMID: 38962684
Introduction: Craniopharyngiomas (CPs) are benign brain tumors accounting for 5 - 11% of intracranial tumors in children. These tumors often recur and can cause severe morbidity. Postoperative radiotherapy efficiently controls...
6.
Gilis N, Lebrun L, Lolli V, David P, Rodesch M, Bex A, et al.
Brain Spine
. 2024 Mar;
4:102671.
PMID: 38510632
Introduction: The incidence of intramedullary spinal cord tumors ranges from 2 to 4% of all central nervous system tumors. Only 6-8% are astrocytomas. The gold standard to diagnose a spinal...
7.
Kyrilli A, Tacelli N, Russo L, Lebrun L, Salmon I, Russ G, et al.
Eur Thyroid J
. 2023 Nov;
12(6).
PMID: 37992294
Objectives: The aim was to evaluate the clinical, ultrasound (US) and, when indicated, the cytological and histological characteristics of autonomously functioning thyroid nodules (AFTN) in consecutive patients. Methods: A prospective,...
8.
Lebrun L, Salmon I
Curr Opin Oncol
. 2023 Nov;
36(1):13-21.
PMID: 37975316
Purpose Of Review: The assessment of thyroid nodules is a common clinical problem, linked to the high incidence of thyroid nodules in the population and the low incidence of aggressive...
9.
Lebrun L, Allard-Demoustiez S, Salmon I
Curr Opin Oncol
. 2023 Jul;
35(5):347-356.
PMID: 37439536
Purpose Of Review: Primary central nervous system lymphoma (PCNSL) is a rare central nervous system (CNS) malignancy, which represents a heterogenous group of tumors. Among PCNSL, diffuse large B-cell lymphoma...
10.
Lebrun L, Absil L, Remmelink M, De Mendonca R, DHaene N, Gaspard N, et al.
Acta Neuropathol Commun
. 2023 May;
11(1):78.
PMID: 37165453
Introduction: COVID-19-infected patients harbour neurological symptoms such as stroke and anosmia, leading to the hypothesis that there is direct invasion of the central nervous system (CNS) by SARS-CoV-2. Several studies...